Spots Global Cancer Trial Database for stomach cancer
Every month we try and update this database with for stomach cancer cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist) | NCT04198766 | Solid Tumor Non-Small Cell ... Melanoma Head and Neck C... Gastric Cancer Renal Cell Carc... Urothelial Carc... | INBRX-106 - Hex... Pembrolizumab 2... Pembrolizumab 4... | 18 Years - | Inhibrx, Inc. | |
| A Study of Ramucirumab (LY3009806) in Combination With Paclitaxel in Participants With Gastric Cancer | NCT02514551 | Gastric Adenoca... Gastroesophagea... | Ramucirumab Paclitaxel | 18 Years - | Eli Lilly and Company | |
| A Study of [225Ac]-FPI-2059 in Adult Participants With Solid Tumours | NCT05605522 | Pancreatic Duct... Squamous Cell C... Colorectal Canc... Gastric Cancer Ewing Sarcoma NTSR1 Expressin... Neuroendocrine ... | [225]-FPI-2059 [111In]-FPI-205... | 18 Years - | Fusion Pharmaceuticals Inc. | |
| Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers | NCT00848783 | Gastric Cancer Gastric Adenoca... Esophageal Canc... | Irinotecan Cisplatin Surgery Floxuridine Capecitabine | 18 Years - | NYU Langone Health | |
| Safety and Efficacy of the Fully Humanized Anti - VEGF Monoclonal Antibody LYN00101 | NCT03644459 | Ovarian Cancer Cervical Cancer Colorectal Canc... Stomach Cancer | LYN00101 | 18 Years - 80 Years | Lynkcell Inc. | |
| Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions | NCT06267703 | Chronic Atrophi... | Metabolomic pro... | 46 Years - 97 Years | Karolinska Institutet | |
| Metastatic Gastric Cancer FFCD 03-07 | NCT00374036 | Stomach Cancer Neoplasm Metast... | ECC FOLFIRI | 18 Years - | University Hospital, Toulouse | |
| A Phase 2 Study of Ramucirumab (LY3009806) in Participants With Gastric or Gastroesophageal Junction (GEJ) Cancer | NCT02443883 | Gastric Adenoca... Gastroesophagea... | Ramucirumab | 18 Years - | Eli Lilly and Company | |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer | NCT01016639 | Stomach Cancer Gall Bladder Ca... Bile Ductus Can... Pancreas Cancer Colorectal Canc... | oxaliplatin, ca... | 18 Years - | Lund University Hospital | |
| BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer | NCT03838406 | BRCA Gene Rearr... | BRCA 1 Chemotherapy | 19 Years - | Chung-Ang University | |
| Patient Reported Outcomes Study Using Electronic Monitoring System for Advanced or Metastatic Solid Cancer | NCT05931445 | Breast Cancer Lung Cancer Colorectal Canc... Liver Cancer Stomach Cancer Endometrial Can... Ovarian Cancer Squamous Cell C... | e-PRO monitorin... | 18 Years - | Comprehensive Support Project for Oncology Research | |
| PARP Inhibitor CVL218 in Combination Therapy for Patients With Advanced Solid Tumors | NCT06078670 | Advanced Solid ... | CVL218 | 18 Years - 75 Years | Fujian Cancer Hospital | |
| A Study of Metastatic Gastrointestinal Cancers Treated With Tumor Infiltrating Lymphocytes in Which the Gene Encoding the Intracellular Immune Checkpoint CISH Is Inhibited Using CRISPR Genetic Engineering | NCT04426669 | Gastrointestina... Gastrointestina... Cancer of Gastr... Cancer, Gastroi... Gastrointestina... Colo-rectal Can... Pancreatic Canc... Gall Bladder Ca... Colon Cancer Esophageal Canc... Stomach Cancer | Cyclophosphamid... Fludarabine Tumor-Infiltrat... Aldesleukin | 18 Years - 70 Years | Intima Bioscience, Inc. | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | NCT03715933 | Solid Tumors Malignant Pleur... Gastric Adenoca... Colorectal Aden... Sarcoma Pancreatic Aden... Ewing Sarcoma Chondrosarcoma GIST SDH-deficient S... | INBRX-109 Carboplatin Cisplatin Pemetrexed 5-fluorouracil Irinotecan Temozolomide | 12 Years - 85 Years | Inhibrx Biosciences, Inc | |
| A Phase 1a/1b Study of ACTM-838 in Patients With Advanced Solid Tumors | NCT06336148 | Solid Tumor | ACTM-838 | 18 Years - | Actym Therapeutics, Inc. | |
| Comparison of Endoscopic Resection and Surgery for Early Gastric Cancer With Undifferentiated Histological Type | NCT04890171 | Stomach Cancer Undifferentiate... Expanded Indica... | Endoscopic subm... Surgery | 19 Years - 75 Years | National Cancer Center, Korea | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| Predictors of Tumor Response and of Radiation Therapy Side Effects in Patients With Gastrointestinal Cancers | NCT01445327 | Esophageal Canc... Stomach Cancer Pancreatic Canc... | Specimen collec... | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| FLOT vs. FLOT/Ramucirumab for Perioperative Therapy of Gastric or GEJ Cancer (RAMSES) | NCT02661971 | Stomach Cancer Gastroesophagea... | Docetaxel Oxaliplatin Calciumfolinat 5-Fluorouracil Ramucirumab | 18 Years - 70 Years | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | NCT05415475 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Safety and Efficacy Study of ALT-801 to Treat Progressive Metastatic Malignancies | NCT00496860 | Progressive Met... | ALT-801 | 18 Years - | Altor BioScience | |
| Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | NCT02545504 | Gastric Adenoca... | Andecaliximab Placebo Leucovorin 5-fluorouracil Oxaliplatin | 18 Years - | Gilead Sciences | |
| A Study With Health Educational Material on Health Promotion in Cancer Survivors | NCT00948337 | Stomach Cancer Colon Cancer Thyroid Cancer Breast Cancer | Brochure of Sec... | 18 Years - 80 Years | National Cancer Center, Korea | |
| A Prospective Cohort Study of Occupational Exposures and Cancer Risk Among Women | NCT00342004 | Lung Cancer Non-Hodgkin Lym... Breast Cancer Stomach Cancer Brain Cancer | 40 Years - 70 Years | National Institutes of Health Clinical Center (CC) | ||
| PRospective rEgistry OF Advanced Stage cancER (PREFER) Patients to Assess Prevalence of Actionable Biomarkers and Driver Mutations to Address Disparities in Precision Medicine | NCT05697198 | Lung Cancer Ovarian Cancer Uterine Cancer Colorectal Canc... Stomach Cancer Esophageal Canc... Pancreatic Canc... Melanoma Breast Cancer Head and Neck C... Soft Tissue Sar... Rhabdomyosarcom... Prostate Cancer | OmniSeq Test | 18 Years - | Labcorp Corporation of America Holdings, Inc | |
| Preoperative Chemo and Chemoradiotherapy for Adenocarcinoma of the Stomach and Gastroesophageal Junction (GEJ) | NCT00525785 | Stomach Cancer Gastric Cancer | 5-Fluorouracil Folinic Acid Oxaliplatin Radiotherapy Surgery | 18 Years - 75 Years | M.D. Anderson Cancer Center | |
| Cancer Experience Registry (CER) for Cancer Patients and Caregivers | NCT02333604 | Neoplasms Cancer Caregiver | 18 Years - | Cancer Support Community, Research and Training Institute, Philadelphia | ||
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer | NCT01246960 | Stomach Cancer Esophageal Canc... | Ramucirumab Placebo Oxaliplatin Leucovorin 5-Fluorouracil | 18 Years - | Eli Lilly and Company | |
| EQUITY GI: A Prospective Study to Enhance Quality, Inclusivity, and Trial Participation in Black Patients With Gastrointestinal Cancer. | NCT06263088 | Gastrointestina... Colon Cancer Rectal Cancer Anal Cancer Esophageal Canc... Stomach Cancer Appendix Cancer Pancreas Cancer Liver Cancer Neuroendocrine ... | EQUITY GI | 18 Years - | Case Comprehensive Cancer Center | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | NCT05415475 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Second-Line Chemotherapy With Ramucirumab +/- Paclitaxel in Elderly Advanced Gastric or Gastroesophageal Junction Cancer Patients | NCT03760822 | Stomach Cancer Stomach Neoplas... Gastric Cancer Gastroesophagea... | Ramucirumab Paclitaxel | 70 Years - | Federation Francophone de Cancerologie Digestive | |
| The Use of 18F-ALF-NOTA-PRGD2 PET/CT Scan to Predict the Efficacy and Adverse Events of Apatinib in Malignancies. | NCT03384511 | Malignancies Stomach Cancer Non-small Cell ... Esophageal Canc... Breast Cancer Ovary Cancer Cervical Cancer | Apatinib | 18 Years - | Shandong Cancer Hospital and Institute | |
| Clinical Study on Raman Spectra of Blood, Saliva and Urine in Patients With Cancer Treated by Modern Therapy | NCT04215861 | Lung Cancer Liver Cancer Stomach Cancer Breast Cancer | 18 Years - 80 Years | The First Affiliated Hospital of Dalian Medical University | ||
| Clinical Study of Pan-cancer DNA Methylation Test in Plasma | NCT05685524 | Cancer | DNA methylation... | 18 Years - 80 Years | Wuhan Ammunition Life-tech Co., Ltd | |
| Pre-operation Chemo and Antibody Therapy Followed by Surgical Resection and Adjuvant Chemoradiation for Gastric Cancer | NCT00857246 | Gastric Cancer Stomach Cancer | Cetuximab Irinotecan Cisplatin Surgery 5-FU Radiation | 18 Years - | NYU Langone Health | |
| DS-8201a in Patients With Cancer That Tests Positive for Human Epidermal Growth Factor Receptor 2 (HER2) Protein | NCT03368196 | Adenocarcinoma,... Neoplasm, Breas... | DS-8201a | 20 Years - | Daiichi Sankyo | |
| Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | NCT02545504 | Gastric Adenoca... | Andecaliximab Placebo Leucovorin 5-fluorouracil Oxaliplatin | 18 Years - | Gilead Sciences | |
| Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy | NCT00622804 | Stomach Cancer Gastrectomy | Billroth-II (B-... Roux en Y gastr... uncut Roux en Y... | 20 Years - 75 Years | The Catholic University of Korea | |
| Adjuvant Intraperitoneal Floxuridine Added to Chemoradiation for Fully Resected Advanced Stomach Cancer | NCT00858338 | Gastric Cancer Stomach Cancer | Potentially cur... Floxuridine (IP... Adjuvant Chemor... | 18 Years - | NYU Langone Health | |
| Quality of Life Among Long-Term Survivors of Resected Gastric Cancer | NCT00598546 | Gastric Cancer | EORTC QLQ-C30, ... | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Study of Motexafin Gadolinium and Docetaxel for Advanced Cancer | NCT00120939 | Breast Neoplasm... Ovarian Neoplas... Prostatic Neopl... Lung Neoplasms Gastrointestina... | Motexafin Gadol... | 18 Years - | Pharmacyclics LLC. | |
| Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors | NCT03662204 | Breast Cancer Lung Cancer Colorectal Canc... Prostate Cancer Bladder Cancer Uterine Cancer Kidney Cancer Renal Pelvis Ca... Pancreatic Canc... Liver Cancer Stomach Cancer Ovarian Cancer Esophageal Canc... | Blood Sample Co... | 18 Years - | Exact Sciences Corporation | |
| Cancer Experience Registry (CER) for Cancer Patients and Caregivers | NCT02333604 | Neoplasms Cancer Caregiver | 18 Years - | Cancer Support Community, Research and Training Institute, Philadelphia | ||
| Study of PEP02, Irinotecan or Docetaxel in Gastric or Gastroesophageal Junction Adenocarcinoma | NCT00813072 | Stomach Neoplas... Esophageal Neop... | PEP02 irinotecan docetaxel | 18 Years - | PharmaEngine | |
| KD019 and Trastuzumab in Patients With Esophagus, Gastroesophageal Junction and Stomach Cancer | NCT02205463 | Esophageal Canc... Stomach Cancer | KD019 | 18 Years - | NYU Langone Health | |
| The Influences of Long Periods of Pneumoperitoneum and Head up Position on the Variation of Heart-rate Corrected QT Interval During Robotic-assisted Laparoscopic Gastrectomy - Observational Study | NCT02604979 | Stomach Cancer | 20 Years - 80 Years | Yonsei University | ||
| Multi-omics Analyses on Etiology and Early Detection of Stomach Cancer Precursor Lesions | NCT06267703 | Chronic Atrophi... | Metabolomic pro... | 46 Years - 97 Years | Karolinska Institutet | |
| GI Organ Tracking Via Balloon Applicators | NCT05471401 | Esophageal Canc... Kidney Cancer Larynx Cancer Liver Cancer Lung Cancer Digestive Organ... Intrathoracic--... Respiratory Org... Pancreas Cancer Small Intestine... Stomach Cancer Colon Cancer Rectal Cancer | Balloon-tipped ... | 18 Years - | Washington University School of Medicine | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296322 | Stomach Cancer | cisplatin, mito... | 18 Years - 69 Years | Asan Medical Center | |
| Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas | NCT03715933 | Solid Tumors Malignant Pleur... Gastric Adenoca... Colorectal Aden... Sarcoma Pancreatic Aden... Ewing Sarcoma Chondrosarcoma GIST SDH-deficient S... | INBRX-109 Carboplatin Cisplatin Pemetrexed 5-fluorouracil Irinotecan Temozolomide | 12 Years - 85 Years | Inhibrx Biosciences, Inc | |
| TKM 080301 for Primary or Secondary Liver Cancer | NCT01437007 | Colorectal Canc... Pancreas Cancer... Gastric Cancer ... Breast Cancer W... Ovarian Cancer ... | TKM-080301 | 18 Years - 99 Years | National Institutes of Health Clinical Center (CC) | |
| A Study of Perioperative mFOLFOX6 Plus Pembrolizumab in Patients With Potentially Resectable Adenocarcinoma of the Gastroesophageal Junction (GEJ) and Stomach | NCT02943603 | Adenocarcinoma Stomach Cancer | mFLOFOX6 + pemb... | 18 Years - 75 Years | University of Pittsburgh | |
| Exercise to Reduce Chemotherapy-Induced Peripheral Neuropathy | NCT03515356 | Gastrointestina... Colorectal Canc... Pancreatic Canc... Gastric Cancer Stomach Cancer Esophageal Canc... | MI-Walk Interve... Physical Activi... | 18 Years - | University of Michigan Rogel Cancer Center | |
| A Study of DB-1303 in Advanced/Metastatic Solid Tumors | NCT05150691 | HER2-positive A... | DB-1303 Pertuzumab Inje... Ritonavir Itraconazole | 18 Years - | DualityBio Inc. | |
| Neoadjuvant Capecitabine, Oxaliplatin, Docetaxel and Atezolizumab in Resectable Gastric and GE-junction Cancer (PANDA) | NCT03448835 | Stomach Cancer Gastro Esophage... | Atezolizumab Capecitabine Oxaliplatin Docetaxel | 18 Years - | The Netherlands Cancer Institute | |
| An Investigational Immuno-therapy Study of Relatlimab Plus Nivolumab Compared to Various Standard-of-Care Therapies in Previously Treated Participants With Recurrent, Advanced or Metastatic Gastric Cancer or Gastroesophageal Junction Adenocarcinoma | NCT03704077 | Gastric Cancer Cancer of the S... Stomach Cancer Gastroesophagea... | Relatlimab + Ni... Nivolumab Paclitaxel Ramucirumab | 18 Years - | Bristol-Myers Squibb | |
| The Effect of Mosapride Citrate on Gastrointestinal Motility After Gastrectomy: Prospective, Double Blind Placebo-controlled Study | NCT04493125 | Stomach Cancer | Mosapride citra... Placebo | 18 Years - 79 Years | Gangnam Severance Hospital | |
| Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer | NCT04135781 | Stomach Cancer | nab paclitaxel Tegafur Oxaliplatin Capecitabine | 18 Years - 75 Years | Zhejiang Cancer Hospital | |
| BReast CAncer Genes(BRCA) Expressions in Metastatic Gastric Cancer | NCT03838406 | BRCA Gene Rearr... | BRCA 1 Chemotherapy | 19 Years - | Chung-Ang University | |
| Alpelisib and Paclitaxel in PIK3CA-altered Gastric Cancer | NCT04526470 | Solid Tumor Stomach Cancer | Alpelisib Paclitaxel | 20 Years - | Seoul National University Bundang Hospital | |
| A Study on the Gastrointestinal Disease and Helicobacter Pylori Controlled Long Non-coding RNA | NCT03057171 | Helicobacter Py... Gastric Ulcer Duodenal Ulcer Stomach Cancer | 19 Years - | Yonsei University | ||
| Endoscopic Ultrasonographic Staging and Conventional Endoscopic Staging for Depth of Invasion for Early Gastric Cancer | NCT01832246 | Gastric Tumor Early Gastric C... | 20 Years - 80 Years | Seoul National University Hospital | ||
| A Randomized Controlled Study of Postoperative Adjuvant Chemotherapy of Uracil- Tegafur (UFT) Compared With Surgery Alone (NSAS-GC) | NCT00152243 | Gastric Cancer | UFT (uracil, te... Surgery alone | 20 Years - 75 Years | Taiho Pharmaceutical Co., Ltd. | |
| Early Onset and Familial Gastric Cancer Registry | NCT00582257 | Gastric Cancer | questionnaires | 18 Years - | Memorial Sloan Kettering Cancer Center | |
| Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma | NCT02545504 | Gastric Adenoca... | Andecaliximab Placebo Leucovorin 5-fluorouracil Oxaliplatin | 18 Years - | Gilead Sciences | |
| Oral Vitamin B12 Administration for Vitamin B12 Deficiency After Total Gastrectomy | NCT00699478 | Vitamin B12 Def... | mecobalamin | - | Yonsei University | |
| Perioperative mFOLFOX Plus Pembrolizumab in Gastroesophageal Junction (GEJ) and Stomach Adenocarcinoma | NCT03488667 | Gastro Esophage... Stomach Cancer Adenocarcinoma | Neoadjuvant Tre... Adjuvant Treatm... | 18 Years - 75 Years | University of Kansas Medical Center | |
| Docetaxel, Cisplatin, Irinotecan and Bevacizumab (TPCA) in Metastatic Esophageal and Gastric Cancer | NCT00394433 | Esophageal Canc... Stomach Cancer | Bevacizumab Docetaxel Cisplatin Irinotecan | 18 Years - | Dana-Farber Cancer Institute | |
| Clinical Study of CEA-targeted CAR-T Therapy for CEA-positive Advanced Malignant Solid Tumors | NCT05415475 | Colorectal Canc... Esophageal Canc... Stomach Cancer Pancreatic Canc... Metastatic Tumo... Recurrent Cance... | CEA CAR-T cells | 18 Years - | Chongqing Precision Biotech Co., Ltd | |
| Study of Capecitabine and Oxaliplatin in Combination With Radiotherapy in Patients With Unresectable Gastro-Intestinal Cancer | NCT01016639 | Stomach Cancer Gall Bladder Ca... Bile Ductus Can... Pancreas Cancer Colorectal Canc... | oxaliplatin, ca... | 18 Years - | Lund University Hospital | |
| Trial of Adjuvant Chemotherapy for Gastric Cancer | NCT00296322 | Stomach Cancer | cisplatin, mito... | 18 Years - 69 Years | Asan Medical Center | |
| Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers | NCT03604653 | Stomach Cancer Colorectal Canc... Appendiceal Can... Ovarian Cancer Uterine Cancer Cervical Cancer Fallopian Tube ... Primary Periton... | HIPEC Mitomycin c CDDP 50 CDDP 75 Doxorubicin | 18 Years - | Holy Name Medical Center, Inc. | |
| Fish Oil Supplementation in Gastrointestinal Cancer | NCT02699047 | Gastrointestina... Colorectal Canc... Stomach Cancer | Encapsuled fish... Encapsulated Ol... | 18 Years - 70 Years | Universidade Federal de Santa Catarina | |
| Randomized Phase III Study of TS-1 Alone Versus TS-1 Plus CDDP in Advanced Gastric Cancer | NCT00150670 | Gastric Cancer | TS-1 and cispla... TS-1 | 20 Years - 74 Years | Taiho Pharmaceutical Co., Ltd. | |
| The PLATON Network | NCT05489250 | Hepatocellular ... Cholangiocarcin... Gallbladder Can... Pancreatic Canc... Oesophageal Can... Stomach Cancer | 18 Years - | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | ||
| Comparison Study for Bile Reflux and Gastric Stasis in Patients After Distal Gastrectomy | NCT00622804 | Stomach Cancer Gastrectomy | Billroth-II (B-... Roux en Y gastr... uncut Roux en Y... | 20 Years - 75 Years | The Catholic University of Korea | |
| Ph II of Capecitabine, Carboplatin & Bevacizumab for Gastroesophageal Junction & Gastric Carcinoma | NCT00780494 | Stomach Cancer Gastric (Stomac... Neoplasm of Car... Gastrointestina... | bevacizumab carboplatin capecitabine | 18 Years - | Stanford University | |
| Effect of Precise Grip Strength Training on PICC Catheter-Related Thrombosis in Cancer Patients | NCT05638048 | Lung Cancer Stomach Cancer Breast Cancer Liver Cancer Colon Cancer Rectal Cancer | Precision grip ... Use maximum str... Health educatio... | 18 Years - 60 Years | Qianfoshan Hospital |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
